Organization
Hospital University of Tübingen
1 abstract
Abstract
Subgroup analysis of real-world efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial carcinoma from a European database.Org: Charité University Medicine Berlin, Rotkreuzklinikum Munich, Heinrich-Heine-University, Diakonie-Klinikum Stuttgart, Ruhr University Bochum,